Surrogate markers in HIV disease.
The use of surrogate markers in HIV disease is an attractive method of assessing the efficacy of new treatments more quickly than by using clinical end-points. The characteristics of an ideal surrogate marker and the theoretical dangers of extrapolating properties from one class of drug to another a...
Hoofdauteur: | Peto, T |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
1996
|
Gelijkaardige items
-
The validity of surrogate markers in rheumatic disease.
door: Emery, P, et al.
Gepubliceerd in: (1993) -
High HPgV replication is associated with improved surrogate markers of HIV progression.
door: Gibran Horemheb-Rubio, et al.
Gepubliceerd in: (2017-01-01) -
Study on the functional role of immunoglobulin E as surrogate marker for HIV/AIDS infection
door: Sonaimuthu B, et al.
Gepubliceerd in: (2012-09-01) -
Surrogates Markers of Insulin Resistance
door: Ekhlas Khalid Hameed, et al.
Gepubliceerd in: (2022-05-01) -
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
door: Timo Rath, et al.
Gepubliceerd in: (2014-01-01)